World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
46
Citations
8293
World Ranking
4617
National Ranking
2080

Mieko Toyoda publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mieko Toyoda sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 138 publications — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mieko Toyoda D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mieko Toyoda sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mieko Toyoda is affiliated with Cedars-Sinai Medical Center in the United States. The main field of study for this researcher is Medicine, with a focused emphasis on several subfields, including Transplantation, Epidemiology, Infectious Diseases, Immunology, and Oncology.

Their research covers a range of topics largely related to transplantation and infectious disease processes. Key topics of study include:

  • Renal Transplantation Outcomes and Treatments
  • Cytomegalovirus and herpesvirus research
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Drug-Induced Adverse Reactions
  • Immunodeficiency and Autoimmune Disorders

Recent publications by Mieko Toyoda include:

  • "T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals," 2021, Cellular and Molecular Immunology
  • "Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia," 2020, Clinical Infectious Diseases
  • "Interleukin-6: An Important Mediator of Allograft Injury," 2020, Transplantation
  • "Evaluation of Clazakizumab (Anti-Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts," 2022, Kidney International Reports
  • "The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejection," 2020, American Journal of Transplantation

Frequent coauthors in their work include:

  • Stanley C. Jordan
  • Ashley Vo
  • Edmund Huang
  • Noriko Ammerman
  • Shili Ge

Mieko Toyoda's publications are often featured in the following venues:

  • Transplantation
  • American Journal of Transplantation
  • Pediatric Transplantation
  • Cellular and Molecular Immunology
  • Clinical Infectious Diseases

Best Publications

  • Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation

    Ashley A Vo;Marina Lukovsky;Mieko Toyoda;Jennifer Wang

  • Evaluation of Intravenous Immunoglobulin as an Agent to Lower Allosensitization and Improve Transplantation in Highly Sensitized Adult Patients with End-Stage Renal Disease: Report of the NIH IG02 Trial

    Stanley C. Jordan;Stanley C. Jordan;Dolly Tyan;Don Stablein;Matthew McIntosh

  • Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.

    McDiarmid Sv;Jordan S;Kim Gs;Toyoda M

  • IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.

    Stanley C. Jordan;Tomas Lorant;Jua Choi;Christian Kjellman

  • Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients.

    Jua Choi;Olivier Aubert;Ashley Vo;Alexandre Loupy

  • Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.

    Ashley A. Vo;Alice Peng;Mieko Toyoda;Joseph Kahwaji

  • Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.

    S. C. Jordan;A. Vo;S. Bunnapradist;M. Toyoda

  • Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade.

    Stanley C. Jordan;Jua Choi;Irene Kim;Gordon Wu

  • Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy

    Asha Moudgil;Cynthia C. Nast;Arvind Bagga;Lin Wei

  • A Phase I/II Trial of the Interleukin-6 Receptor–Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients

    Ashley A. Vo;Jua Choi;Irene Kim;Sabrina Louie

  • Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients.

    S. C. Jordan;A. A. Vo;A. Peng;M. Toyoda

  • Clinical Aspects of Intravenous Immunoglobulin Use in Solid Organ Transplant Recipients

    S. C. Jordan;M. Toyoda;J. Kahwaji;A. A. Vo

  • A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients.

    Ashley A. Vo;Adriana Zeevi;Jua Choi;Kristen Cisneros

  • The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation

    Ragini Fredrich;Mieko Toyoda;Lawrence S.c. Czer;Karine Galfayan

  • Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients.

    Ashley A. Vo;Jua Choi;Kristen Cisneros;Nancy Reinsmoen

  • Intravenous immunoglobulin a natural regulator of immunity and inflammation.

    Stanley C. Jordan;Mieko Toyoda;Ashley A. Vo

  • Cellular immune responses to cytomegalovirus in renal transplant recipients.

    Raju Radha;Stanley Jordan;Dechu Puliyanda;Suphamai Bunnapradist

  • Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin.

    Joseph Kahwaji;Aditi Sinha;Mieko Toyoda;Shili Ge

  • Current approaches to treatment of antibody-mediated rejection.

    Stanley C. Jordan;Ashley A. Vo;Dolly Tyan;Cynthia C. Nast

  • Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells.

    Mieko Toyoda;Andy Pao;Anna Petrosian;Stanley C. Jordan

  • Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient.

    D.P. Puliyanda;N.S. Silverman;D. Lehman;A. Vo

Frequent Co-Authors

Stanley C. Jordan
Stanley C. Jordan Cedars-Sinai Medical Center
Mark Haas
Mark Haas Cedars-Sinai Medical Center
David W. P. Thomas
David W. P. Thomas University of Nottingham
Mikael Knip
Mikael Knip University of Helsinki
David L. Thomas
David L. Thomas Johns Hopkins University
John S. Adams
John S. Adams University of California, Los Angeles
Masato Kasuga
Masato Kasuga National Center For Global Health and Medicine
Lars Bäckman
Lars Bäckman Karolinska Institute
Mats Bengtsson
Mats Bengtsson Royal Institute of Technology
Erik G. Larsson
Erik G. Larsson Linköping University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Nursing pathways, for instance, often intersect with immunological knowledge, especially in areas like infectious diseases and patient care.

Many aspiring nurses benefit from flexible learning options such as the 12-month accelerated nursing programs, which allow quicker entry into the workforce. Similarly, those seeking foundational nursing roles might consider easy admission LPN programs that provide accessible pathways into nursing careers.

For advanced practice roles, pursuing the easiest nurse practitioner program can be a strategic choice for balancing studies with professional demands. This is particularly relevant for those aiming to integrate immunological expertise in clinical settings.

Additionally, specialized fields like mental health nursing benefit from immunological insights. Programs such as the best online psychiatric mental health nurse practitioner programs offer robust clinical placements, preparing graduates for impactful careers at the intersection of immunology and mental health.

Best Scientists Citing Mieko Toyoda

Trending Scientists

Recently Published Articles